The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema

JAMA Dermatology

Volumn 151, Issue 11, 2015, Pages 1187-1193

  Karaca Mandic, Pinar ^a   Hirsch, Alan T ^b   Rockson, Stanley G ^c   Ridner, Sheila H ^d,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF NURSING   (United States)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BREAST CANCER; CELLULITIS; CHILD; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; INFANT; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; NEWBORN; OBESITY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CANCER; UROGENITAL TRACT CANCER; AMBULATORY CARE; COMPLICATION; ECONOMICS; HEALTH INSURANCE; HOSPITALIZATION; MULTIVARIATE ANALYSIS; NEOPLASM; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADULT; AGED; AMBULATORY CARE; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; LYMPHEDEMA; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84946843920     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.1895     Document Type: Article

References (24)

1. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147-154.
2. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138-5149.
3. Al-Niaimi F, Cox N. Cellulitis and lymphedema: a vicious cycle. J Lymphoedema. 2009;4(2):38-42.
4. Swartz MN. Clinical practice: cellulitis. N Engl J Med. 2004;350(9):904-912.
5. Brayton KM, Hirsch AT, O Brien PJ, Cheville A, Karaca-Mandic P, Rockson SG. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS One. 2014;9(12):e114597.
6. FuMR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22(7):1466-1484.
7. Ridner SH, Deng J, FuMR, et al. Symptom burden and infection occurrence among individuals with extremity lymphedema. Lymphology. 2012;45 (3):113-123.
8. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8-24.
9. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46(1):1-11.
10. Adams KE, Rasmussen JC, Darne C, et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express. 2010;1(1):114-125.
11. Muluk SC, Hirsch AT, Taffe EC. Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes. Eur J Vasc Endovasc Surg. 2013;46(4):480-487.
12. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema: a randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002;95(11):2260-2267.
13. Pappas CJ, O'Donnell TF Jr. Long-term results of compression treatment for lymphedema. J Vasc Surg. 1992;16(4):555-562.
14. Berlin E, Gjöres JE, Ivarsson C, Palmqvist I, Thagg G, Thulesius O. Postmastectomy lymphoedema: treatment and a five-year follow-up study. Int Angiol. 1999;18(4):294-298.
15. Ridner SH, Murphy B, Deng J, Kidd N, Galford E, DietrichMS. Advanced pneumatic therapy in self-care of chronic lymphedema of the trunk. Lymphat Res Biol. 2010;8(4):209-215.
16. Ridner SH, McMahon E, DietrichMS, Hoy S. Home-based lymphedema treatment in patients with cancer-related lymphedema or noncancer-related lymphedema. Oncol Nurs Forum. 2008;35(4):671-680.
17. Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. Agency for Healthcare Research and Quality. http://archive.ahrq.gov/downloads/pub /evidence/pdf/efftrials/efftrials.pdf. Accessed June 1, 2015.
18. Fife CE, Davey S, Maus EA, Guilliod R,Mayrovitz HN. A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home. Support Care Cancer. 2012;20(12):3279-3286.
19. Wilburn O,Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer. 2006;6:84.
20. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43 (11):1130-1139.
21. Woolridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2002.
22. Huber PJ. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability: The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions. Berkeley: University of California Press; 1967:221-233.
23. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48(4): 817-838.
24. Tay EY, Fook-Chong S, Oh CC, Thirumoorthy T, Pang SM, Lee HY. Cellulitis Recurrence Score: a tool for predicting recurrence of lower limb cellulitis. J AmAcad Dermatol. 2015;72(1):140-145.